Inducible Prmt1 ablation in adult vascular smooth muscle leads to contractile dysfunction and aortic dissection
10.1038/s12276-021-00684-x · doi-reference
10.3389/fphys.2020.609733
10.3389/fphys.2020.609733 · doi-reference
Modulating the modulators: Regulation of protein arginine methyltransferases by post-translational modifications
10.1016/j.drudis.2020.06.031 · doi-reference
Modulation of I(Ks) channel-PIP(2) interaction by PRMT1 plays a critical role in the control of cardiac repolarization
10.1002/jcp.30775 · doi-reference
SCN5A channelopathy: Arrhythmia, cardiomyopathy, epilepsy and beyond
10.1098/rstb.2022.0164 · doi-reference
Prmt7 regulates the JAK/STAT/Socs3 signaling pathway in postmenopausal cardiomyopathy
10.1038/s12276-024-01193-3 · doi-reference
Adriamycin induces cardiac fibrosis in mice via PRMT5-mediated cardiac fibroblast activation
10.1038/s41401-022-00963-x · doi-reference
PP2A-B55alpha controls keratinocyte adhesion through dephosphorylation of the Desmoplakin C-terminus
10.1038/s41598-023-37874-8 · doi-reference
GSK3- and PRMT-1-dependent modifications of desmoplakin control desmoplakin-cytoskeleton dynamics
10.1083/jcb.201406020 · doi-reference
PRMT5 Prevents Dilated Cardiomyopathy via Suppression of Protein O-GlcNAcylation
10.1161/circresaha.121.319456 · doi-reference
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications
10.1016/j.coph.2020.08.005 · doi-reference
PRMT1 Deficiency in Mouse Juvenile Heart Induces Dilated Cardiomyopathy and Reveals Cryptic Alternative Splicing Products
10.1016/j.isci.2018.09.023 · doi-reference
PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway
10.1038/s41418-022-00990-5 · doi-reference
TGF-β and WNT signaling pathways in cardiac fibrosis: Non-coding RNAs come into focus
10.1186/s12964-020-00555-4 · doi-reference
Matrifibrocytes Redefine Cardiac Fibrosis: From Terminal Differentiation to Translational Modulation
10.1111/jcmm.71174 · doi-reference
10.1101/2024.05.24.595777
10.1101/2024.05.24.595777 · doi-reference
PRMT7 ablation in cardiomyocytes causes cardiac hypertrophy and fibrosis through β-catenin dysregulation
10.1007/s00018-021-04097-x · doi-reference
Genomic Location of PRMT6-Dependent H3R2 Methylation Is Linked to the Transcriptional Outcome of Associated Genes
10.1016/j.celrep.2018.08.052 · doi-reference
Protein arginine methyltransferase 6 mediates cardiac hypertrophy by differential regulation of histone H3 arginine methylation
10.1016/j.heliyon.2020.e03864 · doi-reference
Cardiac Nonmyocytes in the Hub of Cardiac Hypertrophy
10.1161/circresaha.117.305349 · doi-reference
Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice
10.1038/s41467-024-46711-z · doi-reference
TAK1 Activation by NLRP3 Deficiency Confers Cardioprotection Against Pressure Overload-Induced Cardiomyocyte Pyroptosis and Hypertrophy
10.1016/j.jacbts.2023.05.008 · doi-reference
Increased β-catenin accumulation and nuclear translocation are associated with concentric hypertrophy in cardiomyocytes
10.1016/j.carpath.2017.07.003 · doi-reference
10.3390/life11101074
10.3390/life11101074 · doi-reference
PRMT5 up-regulation improves myocardial hypertrophy by mediating E2F-1/NF-κB/NLRP3 pathway
10.1016/j.ypmed.2023.107553 · doi-reference
Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin
10.1016/j.phrs.2020.105104 · doi-reference
10.3389/fphar.2020.600627
10.3389/fphar.2020.600627 · doi-reference
10.3389/fphar.2023.1264216
10.3389/fphar.2023.1264216 · doi-reference
Tropomyosin-troponin complex in inherited cardiomyopathies
10.1016/j.hrthm.2024.02.034 · doi-reference
The inhibitory subunit of cardiac troponin (cTnI) is modified by arginine methylation in the human heart
10.1016/j.ijcard.2019.01.102 · doi-reference
PRMT1 alleviates isoprenaline-induced myocardial hypertrophy by methylating SRSF1
10.3724/abbs.2024175 · doi-reference
Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation
10.1038/s41467-018-07606-y · doi-reference
Physiological and unappreciated roles of CaMKII in the heart
10.1007/s00395-018-0688-8 · doi-reference
Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment
10.31083/j.rcm2503093 · doi-reference
10.3390/jcm12072606
10.3390/jcm12072606 · doi-reference
Prmt1 upregulated by Hdc deficiency aggravates acute myocardial infarction via NETosis
10.1016/j.apsb.2021.10.016 · doi-reference
PRMT1 suppresses doxorubicin-induced cardiotoxicity by inhibiting endoplasmic reticulum stress
10.1016/j.cellsig.2022.110412 · doi-reference
Prmt7 promotes myoblast differentiation via methylation of p38MAPK on arginine residue 70
10.1038/s41418-019-0373-y · doi-reference
PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis
10.1016/j.bbrc.2019.10.085 · doi-reference
Protein arginine methyltransferase 5-mediated arginine methylation stabilizes Kruppel-like factor 4 to accelerate neointimal formation
10.1093/cvr/cvad080 · doi-reference
